Cargando…

Effect of ACE1 polymorphism rs1799752 on protein levels of ACE2, the SARS-CoV-2 entry receptor, in alveolar lung epithelium

Increased protein levels of ACE2 in alveolar epithelium of subjects who are homozygous for the ACE1 insertion of rs1799752 might facilitate host cell entry of #SARSCoV2 and explain the higher prevalence of #COVID19 in certain regions https://bit.ly/3k6aAE8

Detalles Bibliográficos
Autores principales:	Jacobs, Merel, Lahousse, Lies, Van Eeckhoutte, Hannelore P., Wijnant, Sara R.A., Delanghe, Joris R., Brusselle, Guy G., Bracke, Ken R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2021
Materias:	Original Research Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917434/ https://www.ncbi.nlm.nih.gov/pubmed/33889638 http://dx.doi.org/10.1183/23120541.00940-2020

Ejemplares similares

Increased expression of ACE2, the SARS-CoV-2 entry receptor, in alveolar and bronchial epithelium of smokers and COPD subjects
por: Jacobs, Merel, et al.
Publicado: (2020)

The ACE rs1799752 Variant Is Associated with COVID-19 Severity but Is Independent of Serum ACE Activity in Hospitalized and Recovered Patients
por: Fricke-Galindo, Ingrid, et al.
Publicado: (2023)

Association of ACE1 I/D rs1799752 and ACE2 rs2285666 polymorphisms with the infection and severity of COVID‐19: A meta‐analysis
por: Aziz, Md. Abdul, et al.
Publicado: (2022)

The impact of ACE2 polymorphisms (rs1978124, rs2285666, and rs2074192) and ACE1 rs1799752 in the mortality rate of COVID-19 in different SARS-CoV-2 variants
por: Sheikhian, Farzaneh, et al.
Publicado: (2023)

ACE1 rs1799752 polymorphism is not associated with long-COVID symptomatology in previously hospitalized COVID-19 survivors
por: Fernández-de-las-Peñas, César, et al.
Publicado: (2023)

ACE polymorphism and COVID-19 outcome
por: Delanghe, Joris R., et al.
Publicado: (2020)

Effect of age on human ACE2 and ACE2-expressing alveolar type II cells levels
por: Silva, Mauro G., et al.
Publicado: (2022)

ACE2 and Diabetes: ACE of ACEs?
por: Batlle, Daniel, et al.
Publicado: (2010)

Prevalence of Asthma and COPD and Blood Eosinophil Count in a Middle-Aged Belgian Population
por: Wijnant, Sara R. A., et al.
Publicado: (2019)

Lung Function Impairment and the Risk of Incident Dementia: The Rotterdam Study
por: Xiao, Tian, et al.
Publicado: (2021)

Blood eosinophil level and lung function trajectories: cross-sectional and longitudinal studies in European cohorts
por: Mogensen, Ida, et al.
Publicado: (2020)

SNPs of ACE1 (rs4343) and ACE2 (rs2285666) genes are linked to SARS-CoV-2 infection but not with the severity of disease
por: Alimoradi, Nahid, et al.
Publicado: (2022)

Frailty Transitions in Older Persons With Lung Function Impairment: A Population-Based Study
por: Wijnant, Sara R A, et al.
Publicado: (2022)

Severity of coronavirus disease 19: Profile of inflammatory markers and ACE (rs4646994) and ACE2 (rs2285666) gene polymorphisms in Iraqi patients
por: Mahmood, Zainab S., et al.
Publicado: (2022)

Comparison of cerebral blood flow in subjects with and without chronic obstructive pulmonary disease from the population-based Rotterdam Study
por: Wijnant, Sara R A, et al.
Publicado: (2021)

Global distribution of ACE1 (rs4646994) and ACE2 (rs2285666) polymorphisms associated with COVID-19: A systematic review and meta-analysis
por: Keikha, Masoud, et al.
Publicado: (2022)

Expression of the SARS-CoV-2 ACE2 Receptor in the Human Airway Epithelium
por: Zhang, Haijun, et al.
Publicado: (2020)

Role of ACE, ACE2 and Neprilysin in the Kidney
por: Chappell, Mark C.
Publicado: (2007)

Oral corticosteroid use and sarcopenia-related traits in older people with chronic airway disease: a population-based study
por: Benz, Elizabeth, et al.
Publicado: (2023)

ACE2: The Major Cell Entry Receptor for SARS-CoV-2
por: Scialo, Filippo, et al.
Publicado: (2020)

SARS-CoV-2 Entry: At the Crossroads of CD147 and ACE2
por: Fenizia, Claudio, et al.
Publicado: (2021)

SARS-CoV-2 cell entry beyond the ACE2 receptor
por: Alipoor, Shamila D., et al.
Publicado: (2022)

ACE inhibitors on ACE1, ACE2, and TMPRSS2 expression and spheroid attachment on human endometrial Ishikawa cells
por: Fernando, Sudini R., et al.
Publicado: (2022)

SARS-CoV-2 Cellular Entry Is Independent of the ACE2 Cytoplasmic Domain Signaling
por: Karthika, Thankamani, et al.
Publicado: (2021)

Increased ACE2 Expression in Bronchial Epithelium of COPD Patients who are Overweight
por: Higham, Andrew, et al.
Publicado: (2020)

Angiotensin Converting Enzyme (ACE) and ACE2 Bind Integrins and ACE2 Regulates Integrin Signalling
por: Clarke, Nicola E., et al.
Publicado: (2012)

Assessment of ACE1 variants and ACE1/ACE2 expression in COVID-19 patients
por: Akbari, Mohammadarian, et al.
Publicado: (2022)

Cold atmospheric plasma for preventing infection of viruses that use ACE2 for entry
por: Wang, Peiyu, et al.
Publicado: (2022)

ACE2-Independent Bat Sarbecovirus Entry and Replication in Human and Bat Cells
por: Guo, Hua, et al.
Publicado: (2022)

ACE2 and TMPRSS2 in human saliva can adsorb to the oral mucosal epithelium
por: Zhu, Fucun, et al.
Publicado: (2021)

Glycyrrhizin Inhibits SARS-CoV-2 Entry into Cells by Targeting ACE2
por: He, Ming-Feng, et al.
Publicado: (2022)

Physical Activity and Inhibition of ACE Additively Modulate ACE/ACE-2 Balance in Heart Failure in Mice
por: Tyrankiewicz, Urszula, et al.
Publicado: (2021)

Quantification and role of innate lymphoid cell subsets in Chronic Obstructive Pulmonary Disease
por: Blomme, Evy E, et al.
Publicado: (2021)

Identification of critical determinants on ACE2 for SARS-CoV entry and development of a potent entry inhibitor
por: Han, Dong P., et al.
Publicado: (2006)

ACE2 localizes to the respiratory cilia and is not increased by ACE inhibitors or ARBs
por: Lee, Ivan T., et al.
Publicado: (2020)

Differential expression in humans of the viral entry receptor ACE2 compared with the short deltaACE2 isoform lacking SARS-CoV-2 binding sites
por: Williams, Thomas L., et al.
Publicado: (2021)

Targeting transcriptional regulation of SARS-CoV-2 entry factors ACE2 and TMPRSS2
por: Qiao, Yuanyuan, et al.
Publicado: (2021)

ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities
por: Zamorano Cuervo, Natalia, et al.
Publicado: (2020)

MicroRNAs targeting the SARS-CoV-2 entry receptor ACE2 in cardiomyocytes
por: Lu, Dongchao, et al.
Publicado: (2020)

Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2
por: Wang, Qihui, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_avf00u66fg2vm52lk6sk15svcj